(Q33809621)

29 July 2017

1 reference

title

Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Barnes E

1

1 reference

29 July 2017

Webster G

series ordinal

2

1 reference

29 July 2017

Jacobs R

series ordinal

3

1 reference

29 July 2017

Dusheiko G

series ordinal

4

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

244-249

1 reference

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Long-term course of interferon-treated chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Hepatocellular carcinoma (case 2-1996)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Immunopathology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-alpha in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980410-3

7 January 2021

10.1016/S0168-8278(99)80410-3

Identifiers

DOI

1 reference

29 July 2017

1 reference